AJP - GI Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 290: G827-G838, 2006; doi:10.1152/ajpgi.00513.2005
0193-1857/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (29)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brand, S.
Right arrow Articles by Dambacher, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brand, S.
Right arrow Articles by Dambacher, J.

INFLAMMATION/IMMUNITY/MEDIATORS

IL-22 is increased in active Crohn’s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration

Stephan Brand,1,* Florian Beigel,1,* Torsten Olszak,1 Kathrin Zitzmann,1 Sören T. Eichhorst,1 Jan-Michel Otte,2 Helmut Diepolder,1 Andreas Marquardt,3 Wolfgang Jagla,3 Andreas Popp,3 Stéphane Leclair,3 Karin Herrmann,4 Julia Seiderer,1 Thomas Ochsenkühn,1 Burkhard Göke,1 Christoph J. Auernhammer,1 and Julia Dambacher1

1Department of Medicine II, University-Hospital Munich-Grosshadern, University of Munich, Munich, Germany; 2Department of Medicine I, St. Josef-Hospital, Ruhr-University, Bochum, Germany; 3Ingenium Pharmaceuticals, Martinsried, Germany; and 4Institute of Radiology, University-Hospital Munich-Grosshadern, University of Munich, Munich, Germany

Submitted 1 November 2005 ; accepted in final form 18 November 2005

IL-22 is produced by activated T cells and signals through a receptor complex consisting of IL-22R1 and IL-10R2. The aim of this study was to analyze IL-22 receptor expression, signal transduction, and specific biological functions of this cytokine system in intestinal epithelial cells (IEC). Expression studies were performed by RT-PCR. Signal transduction was analyzed by Western blot experiments, cell proliferation by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium assay and Fas-induced apoptosis by flow cytometry. IEC migration was studied in wounding assays. The IEC lines Caco-2, DLD-1, SW480, HCT116, and HT-29 express both IL-22 receptor subunits IL-22R1 and IL-10R2. Stimulation with TNF-{alpha}, IL-1beta, and LPS significantly upregulated IL-22R1 without affecting IL-10R2 mRNA expression. IL-22 binding to its receptor complex activates STAT1/3, Akt, ERK1/2, and SAPK/JNK MAP kinases. IL-22 significantly increased cell proliferation (P = 0.002) and phosphatidylinsitol 3-kinase-dependent IEC cell migration (P < 0.00001) as well as mRNA expression of TNF-{alpha}, IL-8, and human beta-defensin-2. IL-22 had no effect on Fas-induced apoptosis. IL-22 mRNA expression was increased in inflamed colonic lesions of patients with Crohn’s disease and correlated highly with the IL-8 expression in these lesions (r = 0.840). Moreover, IL-22 expression was increased in murine dextran sulfate sodium-induced colitis. IEC express functional receptors for IL-22, which increases the expression of proinflammatory cytokines and promotes the innate immune response by increased defensin expression. Moreover, our data indicate intestinal barrier functions for this cytokine-promoting IEC migration, which suggests an important function in intestinal inflammation and wound healing. IL-22 is increased in active Crohn’s disease and promotes proinflammatory gene expression and IEC migration.

interleukin-10-like cytokines; interleukin-22; defensin



Address for reprint requests and other correspondence: S. Brand, Univ.-Hospital Munich-Grosshadern, Dept. of Medicine II, Univ. of Munich, Marchioninistr. 15, 81377 Munich, Germany (e-mail: stephan.brand{at}med.uni-muenchen.de)




This article has been cited by other articles:


Home page
FASEB J.Home page
L. Charrier-Hisamuddin, C. L. Laboisse, and D. Merlin
ADAM-15: a metalloprotease that mediates inflammation
FASEB J, March 1, 2008; 22(3): 641 - 653.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
J. Dambacher, F. Beigel, J. Seiderer, D. Haller, B. Goke, C. J Auernhammer, and S. Brand
Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease
Gut, September 1, 2007; 56(9): 1257 - 1265.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Zitzmann, S. Brand, E. N. De Toni, S. Baehs, B. Goke, J. Meinecke, G. Spottl, H. H.H.D. Meyer, and C. J. Auernhammer
SOCS1 Silencing Enhances Antitumor Activity of Type I IFNs by Regulating Apoptosis in Neuroendocrine Tumor Cells
Cancer Res., May 15, 2007; 67(10): 5025 - 5032.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
G. F. Weber, S. Schlautkotter, S. Kaiser-Moore, F. Altmayr, B. Holzmann, and H. Weighardt
Inhibition of Interleukin-22 Attenuates Bacterial Load and Organ Failure during Acute Polymicrobial Sepsis
Infect. Immun., April 1, 2007; 75(4): 1690 - 1697.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Brand, J. Dambacher, F. Beigel, K. Zitzmann, M. H. J. Heeg, T. S. Weiss, T. Prufer, T. Olszak, C. J. Steib, M. Storr, et al.
IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro
Am J Physiol Gastrointest Liver Physiol, April 1, 2007; 292(4): G1019 - G1028.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. M. Sa, P. A. Valdez, J. Wu, K. Jung, F. Zhong, L. Hall, I. Kasman, J. Winer, Z. Modrusan, D. M. Danilenko, et al.
The Effects of IL-20 Subfamily Cytokines on Reconstituted Human Epidermis Suggest Potential Roles in Cutaneous Innate Defense and Pathogenic Adaptive Immunity in Psoriasis
J. Immunol., February 15, 2007; 178(4): 2229 - 2240.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.